This inventor holds 2 USPTO granted patents. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Kristy Gotink: Innovator in Chemotherapeutic Treatments
Introduction
Kristy Gotink is a prominent inventor based in Wichmond, Netherlands. She has made significant contributions to the field of medical treatments, particularly in the area of chemotherapeutic agents. With a total of 2 patents, her work focuses on innovative approaches to treating proliferative diseases.
Latest Patents
Kristy Gotink's latest patents include groundbreaking research on the use of hydrophobic weak base compounds as chemotherapeutic agents. These compounds are designed for the treatment of medical conditions characterized by proliferating cells. The patents disclose methods that combine these agents with specific wavelengths of illumination, allowing the hydrophobic weak base compounds to act as effective photosensitizers. This innovative approach aims to enhance the therapeutic effects of the treatment.
Career Highlights
Kristy is associated with the Technion Research & Development Foundation Ltd., where she continues to advance her research in medical treatments. Her work has garnered attention for its potential to improve patient outcomes in the treatment of various proliferative diseases.
Collaborations
Kristy collaborates with notable colleagues, including Henk Verheul and Yamit Adar Turgeman. These partnerships enhance the research and development of her innovative treatments.
Conclusion
Kristy Gotink is a trailblazer in the field of chemotherapeutic innovations. Her patents reflect a commitment to improving medical treatments through innovative approaches. Her contributions are poised to make a significant impact on the future of medical therapies.